

Backed by Clinical Evidence
Safety is confirmed only through rigorous scientific testing, clinical studies, and regulatory review
Only a SureScan® Pacing System satisfies this degree of testing and has FDA approval. It is the first pacing systems designed, tested and approved for MRI use.
- Extensive analysis conducted to evaluate safety using worst-case scenarious:
- Bench testing
- Animal studies
- Computer modeling
- Evaluation in a controlled clinical trial
Revo MRI: A clinical trial confirms the safety of the Revo MRI SureScan Pacing System for patients who need an MRI1
Study Design
- Multicenter, randomized, controlled clinical trial1
- 464 patients received a Revo MRI SureScan Pacing System
- Randomized to elective MRI (MRI Group) or no MRI (Control Group)
- Follow-up: 11.2 5.2 months (mean)
- Pacing systems were interrogated immediately after implant and at regular intervals
- MR imaging intended to represent commonly used, clinically relevant scans
Key Results
- The MRI safety and effectiveness of the Revo MRI SureScan Pacing System was confirmed in patients undergoing MRIs
- Achieved high success rates of clinically equivalent thresholds and sensing amplitudes when compared to control group
- 100% of patients were free of MRI-related complications (n=211, P < 0.001)
- No sustained atrial or ventricular arrhythmias, no asystole, no pacemaker output inhibition, and no electrical resets in the group receiving MRI (n=211)
- Secondary objectives evaluating pacing systemrelated complications and impedance favorably achieved
Advisa MRI: Advisa MRI SureScan system is safe and effective in the MRI environment.
Study Design
- Prospective, randomized controlled, multi-center/263 patients
- Designed to confirm safety and effectiveness of the Advisa MRI SureScan Pacing System
Results
- No MRI related complications
- Similar pacing capture thresholds changes between the MRI and control groups

For further information on the Revo MRI SureScan Pacing System clinical summary results, visit www.medtronic.com/mri.

